NWF Advisory Services Inc. boosted its holdings in abrdn Healthcare Investors (NYSE:HQH – Free Report) by 34.1% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 138,988 shares of the financial services provider’s stock after buying an additional 35,326 shares during the period. NWF Advisory Services Inc. owned 0.26% of abrdn Healthcare Investors worth $2,566,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also made changes to their positions in HQH. Eastern Bank acquired a new stake in abrdn Healthcare Investors in the 3rd quarter valued at $30,000. Newbridge Financial Services Group Inc. acquired a new position in abrdn Healthcare Investors during the 2nd quarter valued at about $34,000. Geneos Wealth Management Inc. increased its holdings in shares of abrdn Healthcare Investors by 9,232.3% during the second quarter. Geneos Wealth Management Inc. now owns 2,893 shares of the financial services provider’s stock valued at $45,000 after purchasing an additional 2,862 shares during the period. Colonial Trust Advisors bought a new stake in abrdn Healthcare Investors during the second quarter worth approximately $57,000. Finally, Ameritas Advisory Services LLC acquired a new stake in abrdn Healthcare Investors in the 2nd quarter valued at about $96,000. 32.60% of the stock is currently owned by institutional investors and hedge funds.
abrdn Healthcare Investors Stock Performance
HQH stock opened at $19.52 on Tuesday. abrdn Healthcare Investors has a 52-week low of $13.77 and a 52-week high of $19.79. The company’s 50 day simple moving average is $19.06 and its 200-day simple moving average is $17.91.
abrdn Healthcare Investors Increases Dividend
About abrdn Healthcare Investors
abrdn Healthcare Investors (NYSE:HQH) is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.
The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth.
Read More
- Five stocks we like better than abrdn Healthcare Investors
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
